Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, today announced two major achievements in its gene therapy program: a commitment...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the closing of a $60 million Series B financing. This funding,...
AllRock Bio Inc., a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, today announced a $50 million Series A round...
Noxilizer, Inc. (“Noxilizer”), the leader in nitrogen dioxide-based terminal sterilization for biopharmaceutical and medical device products, today announced a growth capital financing of $30...
Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of financing led by Lapam Capital, with continued participation...
EnsiliTech, an award-winning biotechnology startup, has raised its second oversubscribed funding round, securing £4.5M in seed funding to improve the way life-saving medicines are...
Axelyf, Inc., a biotechnology company developing next-generation lipid nanoparticle (LNP) delivery systems for RNA therapeutics, today announced the closing of $2.6 million in seed...
Wugen, Inc., a clinical-stage biotechnology company pioneering the next generation of allogeneic, off-the-shelf CAR-T cell therapies, today announced the closing of $115 million equity...
There are a lot of American startups funding deals that are creating buzz around the startup ecosystem. These are the growth-stage and early-stage deals...
